Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly, the Indianapolis-based pharmaceutical company, officially received approval from the Food and Drug Administration for a ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has approved two GLP-1 oral medications, including one by Eli Lilly on Wednesday. File Photo by Jim Lo Scalzo/EPA April 1 ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA approval of the GLP-1 ...

A new weight loss pill from Eli Lilly is hitting the market—and could make one of the fastest-growing drug categories far easier to access. Earlier today, the Food and Drug Administration approved ...

Eli Lilly boasts competitive margins by industry standards. Several initiatives could help the company improve on that front. Since 2020, Eli Lilly's gross and operating margins have improved ...

Foundayo, a new weight loss pill from Eli Lilly, is the first oral GLP-1 that doesn't require fasting. In clinical trials, people lost an average of 8-25 pounds on the drug. One man who took the pill ...

The FDA on April 1 approved Eli Lilly’s daily GLP-1 pill, Foundayo, making it the U.S. market’s second oral GLP-1 drug for treating obesity. Eli Lilly’s Foundayo (orforglipron) is indicated for adults ...

The U.S. Food and Drug Administration on Wednesday gave its approval to Eli Lilly’s GLP-1 weight loss pill. The daily pill, called Foundayo, is the second oral GLP-1 product to reach the market over ...

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...